Use of Introduction Mode to Improve Interactive Voice Response Surveys in Bangladesh and Tanzania

A Randomized Controlled Trial of Varying Introduction Mode to Improve Interactive Voice Response (IVR) Survey Performance in Bangladesh and Tanzania

This study evaluates the effect of two different introduction modes on interactive voice response (IVR) survey cooperation, response, refusal, and contact rates, in Bangladesh and Tanzania.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Using random digit dialing (RDD) sampling techniques, participants were randomized to one of two introduction modes, followed by a noncommunicable disease (NCD) risk factor survey. The two modes were computer assisted telephone interview (CATI), in which a call-center employee read the introduction to a participant and received oral consent from them, before sending them the NCD risk factor survey via IVR, or the entire survey, including the introduction and consent, being obtained via IVR. In IVR surveys, participants use their touch tone key pad to answer pre-recorded questions. (i.e. If you are male, press 1; If you are female, press 2). This study was conducted in both Bangladesh and Tanzania.

Study Type

Interventional

Enrollment (Actual)

1511

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Dhaka, Bangladesh
        • Institute of Epidemiology Disease Control and Research
      • Dar Es Salaam, Tanzania
        • Ifakara Health Institute

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Access to a mobile phone
  • Greater or equal to 18 years of age
  • In Bangladesh, conversant in either English or Bangla language. In Uganda, conversant in either Luo, Luganda, Runyakitara, or English languages.

Exclusion Criteria:

  • Less than 18 years of age

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: CATI
Introduction and consent via computer assisted telephone interview
The participants in this arm were read the introduction and asked for consent by a call center employee using computer-assisted telephone interviewing and then were sent a noncommunicable disease risk factor survey via interactive voice response. This mode was used to motivate participants to complete the survey.
No Intervention: IVR
Introduction and consent via interactive voice response

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cooperation Rate #1
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research, cooperation rate is defined as I/(I+P+R) where I is complete interviews, P is partial interviews, and R is refusals and breakoffs.
Through study completion, an average of one month
Response Rate #4
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research, response rate is defined as (I+P)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns
Through study completion, an average of one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Refusal Rate #2
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research, refusal rate is defined as (R)/(I+P+R+eU) where R is refusals and breakoffs, I is complete interviews, P is partial interviews, and eU is the estimated eligible proportion of unknowns.
Through study completion, an average of one month
Contact Rate #2
Time Frame: Through study completion, an average of one month
As defined by American Association for Public Opinion Research, contact rate is defined as (I+P+R)/(I+P+R+eU) where I is complete interviews, P is partial interviews, R is refusals and breakoffs, and eU is the estimated eligible proportion of unknowns.
Through study completion, an average of one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Adnan A Hyder, PhD, MBBS, Johns Hopkins University Bloomberg School of Public Health
  • Principal Investigator: George W. Pariyo, PhD, Johns Hopkins University Bloomberg School of Public Health

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 14, 2017

Primary Completion (Actual)

August 18, 2017

Study Completion (Actual)

August 18, 2017

Study Registration Dates

First Submitted

December 10, 2018

First Submitted That Met QC Criteria

December 10, 2018

First Posted (Actual)

December 11, 2018

Study Record Updates

Last Update Posted (Actual)

May 22, 2023

Last Update Submitted That Met QC Criteria

May 19, 2023

Last Verified

December 1, 2018

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Noncommunicable Diseases

Clinical Trials on CATI

3
Subscribe